GSK PLC 24 May 2024 Issued: 23 May 2024, London UK Statement: Zantac (ranitidine) litigation - Valadez and Williams cases · Jury in...
GSK PLC on Tuesday announced positive results from trials of depemokimab, an "ultra-long-acting biologic" that could ...
GSK PLC 21 May 2024 Issued: 21 May 2024, London UK GSK announces positive results from phase III severe asthma trials of depemokimab · ...
based pharmaceuticals firm - Senior Vice President, Global Communications & Chief Executive Office, Sally Jackson, buy ...
GSK PLC 20 May 2024 GSK plc (the 'Company') Transaction notification 1. Details of PDMR/person closely associated with them ('PCA') a...
GSK PLC on Friday said it has sold its remaining shares in Haleon PLC, marking a total exit from its consumer healthc ...
GSK PLC 17 May 2024 Issued: 17 May 2024, London UK THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR...
GSK PLC on Thursday said it intends to sell its remaining stake in Haleon PLC, the consumer healthcare firm it spun o ...
GSK PLC 16 May 2024 Issued: 16 May 2024, London UK THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR...
GSK PLC 14 May 2024 GSK plc (the 'Company') Transaction notification 1. Details of PDMR/person closely associated with them ('PCA') a) Name...
GSK PLC 13 May 2024 BLOCK LISTING SIX MONTHLY RETURN Date: 13 May 2024 Name of applicant: GSK plc Name of scheme: GlaxoSmithKline...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.